Evidence map›Paper›PMID 19565126›Full record

ArticleBulletin of the World Health Organization2009

Comparative impact assessment of child pneumonia interventions.

Louis W Niessen, Anne ten Hove, Henk Hilderink, Martin Weber, Kim Mulholland, Majid Ezzati

Abstract readComparative Study
In one paragraph

Article in Bulletin of the World Health Organization, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Vitamin C supplementation for prevention and treatment of pneumonia.The Cochrane database of systematic reviews · 2021
    Pooled it
  5. Vitamin C supplementation for prevention and treatment of pneumonia.The Cochrane database of systematic reviews · 2020
    Pooled it
  6. Pooled it
  7. Oral amoxicillin versus benzyl penicillin for severe pneumonia among kenyan children: a pragmatic randomized controlled noninferiority trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2015
    Trial
  8. Non-COVID-19 respiratory tract infection mortality among children under 5 years old: a time series, Brazil, 2002-2022.Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Pneumonia among under-five children in Alexandria, Egypt: a case-control study.The Journal of the Egyptian Public Health Association · 2020
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Optimizing the impact of low-efficacy influenza vaccines.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Louis W NiessenDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, United States of America (USA). lniessen@jhsph.edu
Anne ten Hove
Henk Hilderink
Martin Weber
Kim Mulholland
Majid Ezzati

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare the cost-effectiveness of interventions to reduce pneumonia mortality through risk reduction, immunization and case management.

methodsCountry-specific pneumonia burden estimates and intervention costs from WHO were used to review estimates of pneumonia risk in children under 5 years of age and the efficacy of interventions (case management, pneumonia-related vaccines, improved nutrition and reduced indoor air pollution from household solid fuels). We calculated health benefits (disability-adjusted life years, DALYs, averted) and intervention costs over a period of 10 years for 40 countries, accounting for 90% of pneumonia child deaths.

findingsSolid fuel use contributes 30% (90% confidence interval: 18-44) to the burden of childhood pneumonia. Efficacious community-based treatment, promotion of exclusive breastfeeding, zinc supplementation and Haemophilus influenzae type b (Hib) and Streptococcus pneumoniae immunization through existing programmes showed cost-effectiveness ratios of 10-60 International dollars (I$) per DALY in low-income countries and less than I$ 120 per DALY in middle-income countries. Low-emission biomass stoves and cleaner fuels may be cost-effective in low-income regions. Facility-based treatment is potentially cost-effective, with ratios of I$ 60-120 per DALY. The cost-effectiveness of community case management depends on home visit cost.

conclusionVaccines against Hib and S. pneumoniae, efficacious case management, breastfeeding promotion and zinc supplementation are cost-effective in reducing pneumonia mortality. Environmental and nutritional interventions reduce pneumonia and provide other benefits. These strategies combined may reduce total child mortality by 17%.

Indexed as

ChildChild MortalityChild, PreschoolDeveloping CountriesHealth PromotionHumansInfantInfant MortalityPneumococcal VaccinesPneumoniaRisk FactorsPneumococcal Vaccines

Identifiers

PMID19565126
PMCPMC2686204

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.